Literature DB >> 11239164

Autocrine/paracrine mechanisms in human hematopoiesis.

A Janowska-Wieczorek1, M Majka, J Ratajczak, M Z Ratajczak.   

Abstract

Autocrine/paracrine regulatory mechanisms are believed to play a role in the pathophysiology of several hematologic malignancies. Evidence is accumulating that various growth factors, cytokines, and chemokines are expressed and secreted by normal early and differentiated hematopoietic cells and thus could also regulate normal hematopoiesis in an autocrine/paracrine manner. In this review we summarize recent advances in identification and understanding of the role of autocrine/paracrine axes in the growth of both malignant and normal human hematopoietic cells. Better understanding of intercellular crosstalk operating in normal and pathological states and the mechanisms regulating synthesis of these endogenously produced factors (potential targets for various pharmacological approaches) may allow us to improve antileukemia treatments, undertake more efficient ex vivo stem cell expansion, and develop other therapeutic strategies.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11239164     DOI: 10.1634/stemcells.19-2-99

Source DB:  PubMed          Journal:  Stem Cells        ISSN: 1066-5099            Impact factor:   6.277


  20 in total

1.  Tightly anchored tissue-mimetic matrices as instructive stem cell microenvironments.

Authors:  Marina C Prewitz; F Philipp Seib; Malte von Bonin; Jens Friedrichs; Aline Stißel; Christian Niehage; Katrin Müller; Konstantinos Anastassiadis; Claudia Waskow; Bernard Hoflack; Martin Bornhäuser; Carsten Werner
Journal:  Nat Methods       Date:  2013-06-23       Impact factor: 28.547

2.  Soluble Signals and Remodeling in a Synthetic Gelatin-Based Hematopoietic Stem Cell Niche.

Authors:  Aidan E Gilchrist; Sunho Lee; Yuhang Hu; Brendan A C Harley
Journal:  Adv Healthc Mater       Date:  2019-09-18       Impact factor: 9.933

3.  Pro-Angiogenic Actions of CMC-Derived Extracellular Vesicles Rely on Selective Packaging of Angiopoietin 1 and 2, but Not FGF-2 and VEGF.

Authors:  Marcin Wysoczynski; Asif Pathan; Joseph B Moore; Talha Farid; Jae Kim; Marjan Nasr; Yi Kang; Hong Li; Roberto Bolli
Journal:  Stem Cell Rev Rep       Date:  2019-08       Impact factor: 5.739

Review 4.  Hematopoietic stem and progenitor cell signaling in the niche.

Authors:  Stephanie N Hurwitz; Seul K Jung; Peter Kurre
Journal:  Leukemia       Date:  2020-10-19       Impact factor: 11.528

5.  Therapeutic potential of vasculogenesis and osteogenesis promoted by peripheral blood CD34-positive cells for functional bone healing.

Authors:  Tomoyuki Matsumoto; Atsuhiko Kawamoto; Ryosuke Kuroda; Masakazu Ishikawa; Yutaka Mifune; Hiroto Iwasaki; Masahiko Miwa; Miki Horii; Saeko Hayashi; Akira Oyamada; Hiromi Nishimura; Satoshi Murasawa; Minoru Doita; Masahiro Kurosaka; Takayuki Asahara
Journal:  Am J Pathol       Date:  2006-10       Impact factor: 4.307

6.  Thrombopoietin enhances expression of vascular endothelial growth factor (VEGF) in primitive hematopoietic cells through induction of HIF-1alpha.

Authors:  Keita Kirito; Norma Fox; Norio Komatsu; Kenneth Kaushansky
Journal:  Blood       Date:  2005-02-10       Impact factor: 22.113

7.  Regulating dynamic signaling between hematopoietic stem cells and niche cells via a hydrogel matrix.

Authors:  Bhushan P Mahadik; Narayanan A K Bharadwaj; Randy H Ewoldt; Brendan A C Harley
Journal:  Biomaterials       Date:  2017-02-14       Impact factor: 12.479

Review 8.  Stem cells and their potential clinical applications in psychiatric disorders.

Authors:  Mariusz Z Ratajczak; Andrzej K Ciechanowicz; Jolanta Kucharska-Mazur; Jerzy Samochowiec
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2017-04-20       Impact factor: 5.067

9.  Paracrine proangiopoietic effects of human umbilical cord blood-derived purified CD133+ cells--implications for stem cell therapies in regenerative medicine.

Authors:  Janina Ratajczak; Magda Kucia; Kasia Mierzejewska; Wojciech Marlicz; Zbigniew Pietrzkowski; Wojciech Wojakowski; Nicholas J Greco; Michal Tendera; Mariusz Z Ratajczak
Journal:  Stem Cells Dev       Date:  2012-11-05       Impact factor: 3.272

10.  Growth factor independence underpins a paroxysmal, aggressive Wnt5aHigh/EphA2Low phenotype in glioblastoma stem cells, conducive to experimental combinatorial therapy.

Authors:  Nadia Trivieri; Alberto Visioli; Gandino Mencarelli; Maria Grazia Cariglia; Laura Marongiu; Riccardo Pracella; Fabrizio Giani; Amata Amy Soriano; Chiara Barile; Laura Cajola; Massimiliano Copetti; Orazio Palumbo; Federico Legnani; Francesco DiMeco; Leonardo Gorgoglione; Angelo L Vescovi; Elena Binda
Journal:  J Exp Clin Cancer Res       Date:  2022-04-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.